Beautiful Virgin Islands

Thursday, Sep 18, 2025

US stuck in a 'horrible plateau' of COVID-19 deaths, experts say. Here's why.

US stuck in a 'horrible plateau' of COVID-19 deaths, experts say. Here's why.

"COVID is over" might trend within social media circles, but weekly U.S. death tolls tell a different story.

The pace of COVID-19 deaths has remained relatively steady since May, despite an uptick in July to about 400 a day, according to a USA TODAY analysis of Johns Hopkins University data.

“We’re sitting on this horrible plateau,” said Dr. Daniel Griffin, an infectious disease specialist with Pro Health Care in New York and a clinical instructor of medicine at Columbia University. “It’s been this way for the past couple of months, and we’re getting used to it.”

In July, more than 12,500 Americans died of COVID-19, according to the USA TODAY analysis.

Coronavirus deaths are similar to the number of influenza deaths normally reported during peak season, said David Dowdy, epidemiologist at the Johns Hopkins Bloomberg School of Public Health. A bad flu season in the USA could see more than 50,000 deaths.

That doesn’t mean COVID-19 mortality has reached that of flu, he said, as peak flu season lasts only about three months. Spread over the course of the year, Dowdy said, there would be about four times as many COVID-19 deaths than flu deaths.

COVID-19 is “like having to live in flu season year round, and that’s not what we do with the flu,” he said. “If we had to do that with the flu, we’d be instituting more measures than what we do.”

Most Americans who died of COVID-19 were immunocompromised or older than 75, experts said. These patients ranged in vaccination status – from being unvaccinated to receiving all their recommended vaccines and boosters.

What appears to make the biggest difference between patients who recover from COVID-19 or die, Griffin said, is whether they receive treatment within the first week of diagnosis.

“I can’t remember someone in my recent memory who did all the right things, who got the vaccine and got the proper early treatment, and ended up in the hospital and died,” he said.

The antiviral Paxlovid, from Pfizer, has been effective at keeping high-risk COVID-19 patients out of the hospital. But it’s losing esteem among providers and patients as public figures report rebound infections after taking the antiviral, Griffin said.

President Joe Biden, 79, tested positive for the coronavirus Saturday, three days after he twice tested negative and was thought to have recovered. His chief medical adviser, Dr. Anthony Fauci, 81, reported a rebound infection in June.

Although it appears more rebound infections are reported, Dr. Ashish Jha, the White House's COVID-19 response coordinator, said the rate of cases is probably about 5%. Most people aren’t tested as often as health officials, Jha said in a series of tweets Monday.

It’s not clear whether a rebound after taking the antiviral is different from a rebound without the drug. In the trial that led to Paxlovid’s authorization, 2% of those who took the medication and nearly the same percentage of those who didn’t experienced rebounds.

The uncertainty surrounding antivirals and other COVID-19 treatments may contribute to preventable deaths, Griffin said.

“A lot of clinicians are reading the popular press, and that’s where they’re getting their impression of things,” he said. “You have a five-day opportunity to reduce the disease progression, and once that window is closed, it’s closed.”

A monoclonal antibody called Evusheld fromAstraZeneca prevented severe disease in people with weakened immune systems who may not get full protection from vaccines. It provides long-lasting protection, but Griffin said some providers don’t recommend it to eligible patients.

“It’s not an easy lift,” he said. “You can’t just write a prescription. It’s still only being sent to certain places, and there’s a whole process for getting your patient enrolled.”

Some physicians consider it “an uncompensated and time-consuming lift,” he said, and prescribe other medications that aren’t suitable for early treatment, such as high-dose steroids.

Nearly 92% of Americans over 65 are fully vaccinated, and about 70% have received at least one booster, according to the Centers for Disease Control and Prevention. Reformulated COVID-19 booster shots targeting the omicron variant of the coronavirus are likely this fall, but health experts don’t expect they’ll have a significant impact on the death rate.

“The vaccines we already have are still highly effective against serious illness and deaths … so I don’t think the bivalent vaccines are going to be a game changer in that regard,” Dowdy said. “What they may do is help curb transmission somewhat because they may be more effective against infection.”

Experts said what will protect those at high risk of severe COVID-19 and death is staying up to date on recommended vaccines and seeking early treatment with proven therapies.

“This plateau now, as horrible as it is, is unfortunately lower than it’s going to be if we don’t do a great job this fall with boosters and improving education about how to properly manage COVID,” Griffin said.

Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Macron and his wife to provide 'scientific photographic evidence' that she is a real woman
US Tech Giants Pledge Billions to UK AI Infrastructure Following Starmer's Call
Saudi Arabia cracks down on music ‘lounges’ after conservative backlash
DeepMind and OpenAI Achieve Gold at ‘Coding Olympics’ in AI Milestone
SEC Allows Public Companies to Block Investors from Class-Action Lawsuits
Saudi Arabia Signs ‘Strategic Mutual Defence’ Pact with Pakistan, Marking First Arab State to Gain Indirect Access to Nuclear Strike Capabilities in the Region
Federal Reserve Cuts Rates by Quarter Point and Signals More to Come
Effective and Impressive Generation Z Protest: Images from the Riots in Nepal
European manufacturers against ban on polluting cars: "The industry may collapse"
Sam Altman sells the 'Wedding Estate' in Hawaii for 49 million dollars
Trump: Cancel quarterly company reports and settle for reporting once every six months
Turkish car manufacturer Togg Enters German Market with 5-Star Electric Sedan and SUV to Challenge European EV Brands
US Launches New Pilot Program to Accelerate eVTOL Air Taxi Deployment
Christian Brueckner Released from German Prison after Serving Unrelated Sentence
World’s Longest Direct Flight China Eastern to Launch 29-Hour Shanghai–Buenos Aires Direct Flight via Auckland in December
New OpenAI Study Finds Majority of ChatGPT Use Is Personal, Not Professional
Hong Kong Industry Group Calls for HK$20 Billion Support Fund to Ease Property Market Stress
Joe Biden’s Post-Presidency Speaking Fees Face Weak Demand amid Corporate Reluctance
Charlie Kirk's murder will break the left's hateful cancel tactics
Kash Patel erupts at ‘buffoon’ Sen. Adam Schiff over Russiagate: ‘You are the biggest fraud’
Homeland Security says Emmy speech ‘fanning the flames of hatred’ after Einbinder’s ‘F— ICE’ remark
Charlie Kirk’s Alleged Assassin Tyler Robinson Faces Death Penalty as Charges Formally Announced
Actor, director, environmentalist Robert Redford dies at 89
The conservative right spreads westward: a huge achievement for 'Alternative for Germany' in local elections
JD Vance Says There Is “No Unity” with Those Who Celebrate Charlie Kirk’s Killing, and he is right!
Trump sues the 'New York Times' for an astronomical sum of 15 billion dollars
Florida Hospital Welcomes Its Largest-Ever Baby: Annan, Nearly Fourteen Pounds at Birth
U.S. and Britain Poised to Finalize Over $10 Billion in High-Tech, Nuclear and Defense Deals During Trump State Visit
China Finds Nvidia Violated Antitrust Laws in Mellanox Deal, Deepens Trade Tensions with US
US Air Force Begins Modifications on Qatar-Donated Jet Amid Plans to Use It as Air Force One
Pope Leo Warns of Societal Crisis Over Mega-CEO Pay, Citing Tesla’s Proposed Trillion-Dollar Package
Poland Green-Lights NATO Deployment in Response to Major Russian Drone Incursion
Elon Musk Retakes Lead as World’s Richest After Brief Ellison Surge
U.S. and China Agree on Framework to Shift TikTok to American Ownership
London Daily Podcast: London Massive Pro Democracy Rally, Musk Support, UK Economic Data and Premier League Results Mark Eventful Weekend
This Week in AI: Meta’s Superintelligence Push, xAI’s Ten Billion-Dollar Raise, Genesis AI’s Robotics Ambitions, Microsoft Restructuring, Amazon’s Million-Robot Milestone, and Google’s AlphaGenome Update
Le Pen Tightens the Pressure on Macron as France Edges Toward Political Breakdown
Musk calls for new UK government at huge pro-democracy rally in London, but Britons have been brainwashed to obey instead of fighting for their human rights
Elon Musk responds to post calling for the murder of Erika Kirk, widow of Charlie Kirk: 'Either we fight back or they will kill us'
Czech Republic signs €1.34 billion contract for Leopard 2A8 main battle tanks with delivery from 2028
USA: Office Depot Employees Refused to Print Poster in Memory of Charlie Kirk – and Were Fired
Proposed U.S. Bill Would Allow Civil Suits Against Judges Who Release Repeat Violent Offenders
Penske Media Sues Google Over “AI Overviews,” Claiming It Uses Journalism Without Consent and Destroys Traffic
Indian Student Engineers Propose “Project REBIRTH” to Protect Aircraft from Crashes Using AI, Airbags and Smart Materials
French Debt Downgrade Piles Pressure on Macron’s New Prime Minister
US and UK Near Tech, Nuclear and Whisky Deals Ahead of Trump Trip
One in Three Europeans Now Uses TikTok, According to the Chinese Tech Giant
Could AI Nursing Robots Help Healthcare Staffing Shortages?
NATO Deploys ‘Eastern Sentry’ After Russian Drones Violate Polish Airspace
Anesthesiologist Left Operation Mid-Surgery to Have Sex with Nurse
×